Return-Path: Delivered-To: louk@transocean.com Received: from vps.transocean.com by vps.transocean.com with LMTP id YLzpEmrKu1oFDAAAInt2oQ for ; Wed, 28 Mar 2018 10:01:30 -0700 Return-path: Envelope-to: louk@transocean.com Delivery-date: Wed, 28 Mar 2018 10:01:30 -0700 Received: from omp.news.grceducators.com ([129.145.68.217]:40080 helo=om-axonstech.rsys2.com) by vps.transocean.com with esmtp (Exim 4.89_1) (envelope-from ) id 1f1ERw-0000nn-Rl for louk@transocean.com; Wed, 28 Mar 2018 10:01:30 -0700 DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; s=grceducators; d=news.grceducators.com; h=MIME-Version:Content-Type:Content-Transfer-Encoding:Date:To:From:Reply-To: Subject:List-Unsubscribe:Message-ID; i=grceducators@news.grceducators.com; bh=7L7DWsWCvWxVM1fsz2DHgIIA2/0vyvMlo1KLitRretE=; b=e7dsH+CRt52CLm/oKFLXccKUWUJLWy3kzX5e6AKxngVXwkJQ5lxSCGv9PBlcyChRNSqmlM5QhHGM L7//1eImmcspu6YVcHrxr3DnCMj/FsOWcwVgv2ATmX3nFc6mpLeCQSUxoD37murhcWzqeZ8utXI2 ezzWm7WLWUS+7jCOELyu75FJUYUm3IKW5iFcxs8GRdL7MFYCm1Z2yeC9TLo3WOzbc9s0zLkASv/t Ze9X/mE4rV1lQJrgPDR5eOMHv2E66vv9t1CH0z7Y1bfqDQypIlue3CLFq5EhQpS9VoAPI7yBg8J2 xQxjekS8RcEcQWexzZ8r3ofWeMnHlfsnlRYf6g== Received: by om-axonstech.rsys2.com id hnf56a2b610e for ; Wed, 28 Mar 2018 10:00:45 -0700 (envelope-from ) X-CSA-Complaints: whitelist-complaints@eco.de MIME-Version: 1.0 Content-Type: text/html; charset="ISO-8859-1" Content-Transfer-Encoding: quoted-printable Date: Wed, 28 Mar 2018 10:00:45 -0700 To: louk@transocean.com From: =?ISO-8859-1?B?V2ViaW5hciB1cGRhdGVz?= Reply-To: =?ISO-8859-1?B?V2ViaW5hciB1cGRhdGVz?= Subject: How is Evidence - Based Medicine Related to Coverage of Medical Devices and Why should I care? Feedback-ID: 10775:141562:oraclersys List-Unsubscribe: , X-sgxh1: thmsxljHgkhJLHgQJhu X-rext: 5.interact2.EgXw-OiaSluwU9_v3-tstud8LDZ4hEdGXF6MeFsL8o0EiyQ X-cid: axonstech.146122 Message-ID: <0.1.8E.EC3.1D3C6B64FEBD088.0@om-axonstech.rsys2.com> X-Spam-Status: No, score=2.4 X-Spam-Score: 24 X-Spam-Bar: ++ X-Ham-Report: Spam detection software, running on the system "vps.transocean.com", has NOT identified this incoming email as spam. The original message has been attached to this so you can view it or label similar future email. If you have any questions, see root\@localhost for details. Content preview: Evidence-based Medicine Related to Coverage of Medical Devices. 740-870-0321 How is Evidence –Based Medicine Related to Coverage of Medical Devices and Why should I care? [...] Content analysis details: (2.4 points, 3.0 required) pts rule name description ---- ---------------------- -------------------------------------------------- 0.0 URIBL_BLOCKED ADMINISTRATOR NOTICE: The query to URIBL was blocked. See http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block for more information. [URIs: mailinblue.com] -0.0 T_RP_MATCHES_RCVD Envelope sender domain matches handover relay domain -0.0 SPF_PASS SPF: sender matches SPF record 0.8 BAYES_50 BODY: Bayes spam probability is 40 to 60% [score: 0.5000] 0.0 HTML_FONT_LOW_CONTRAST BODY: HTML font color similar or identical to background 0.7 MIME_HTML_ONLY BODY: Message only has text/html MIME parts 0.0 HTML_MESSAGE BODY: HTML included in message 0.0 AC_DIV_BONANZA RAW: Too many divs in a row... spammy template 0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily valid -0.1 DKIM_VALID_AU Message has a valid DKIM or DK signature from author's domain -0.1 DKIM_VALID Message has at least one valid DKIM or DK signature 1.0 FROM_EXCESS_BASE64 From: base64 encoded unnecessarily X-Spam-Flag: NO <=21DOCTYPE html PUBLIC =22-//W3C//DTD XHTML 1=2E0 Transitional//EN=22 =22h= ttp://www=2Ew3=2Eorg/TR/xhtml1/DTD/xhtml1-transitional=2Edtd=22> Evidence-based Medicine Related to Coverage of Medical Devices=2E= <=21--=5Bif gte mso 11=5D><=21=5Bendif= =5D--><=21--=5Bif =21mso=5D><=21--> <=21--<=21=5Bendif=5D--><=21--=5Bif gte mso 15=5D>96<=21=5Bendif=5D--><=21--=5Bif gte mso 9=5D>96<=21=5Bendif=5D-->
<=21--=5Bif gte mso 9= =5D>
<=21=5Bendif=5D-->
3D=22=22
<=21--=5Bif mso 15=5D> <=21=5Bendif=5D--><=21--=5Bif mso 15=5D> <=21=5Bendif=5D--><=21--=5Bif mso 15=5D>
<=21=5Bendif=5D-->
3D=22=
740-870-0321
<=21--=5Bif mso 15=5D>
<=21=5Bendif=5D-->
<=21--=5Bif mso=5D> <=21=5Bendif=5D--><=21--=5Bif mso=5D> <=21=5Bendif=5D--><=21--=5Bif mso=5D>
<=21=5Bendif=5D-->
<=21--=5Bif mso=5D>
<=21=5Bendif=5D-->
<=21--=5Bif mso=5D> <=21=5Bendif=5D--><=21--=5Bif mso=5D> <=21=5Bendif=5D--><=21--=5Bif mso=5D>
<=21=5Bendif=5D-->
3D=22=22
<=21--=5Bif mso=5D>
<=21=5Bendif=5D-->
<=21--=5Bif mso=5D> <=21=5Bendif=5D--><=21--=5Bif mso=5D> <=21=5Bendif=5D--><=21--=5Bif mso=5D>
<=21=5Bendif=5D-->
How is Evidence =96Based Medicine= Related to Coverage of Medical Devices and Why should I care?
<=21--=5Bif mso=5D>
<=21=5Bendif=5D-->
<=21--=5Bif mso=5D> <=21=5Bendif=5D--><=21--=5Bif mso=5D> <=21=5Bendif=5D--><=21--=5Bif mso=5D>
<=21=5Bendif=5D-->
MONDAY APRIL 16 2018  =7C 01:00 PM EST  = =7C 60 MINUTES
<=21--=5Bif mso=5D>
<=21=5Bendif=5D-->
<=21--=5Bif mso=5D> <=21=5Bendif=5D--><=21--=5Bif mso=5D> <=21=5Bendif=5D--><=21--=5Bif mso=5D>
<=21=5Bendif=5D-->
This webinar is being offered by GRC Educators to pro= vide detailed information to help manufacturers of newly-developed medical = devices understand why coverage of their product by insurers is primarily d= etermined by top-quality research data published in well-designed clinical = trials published in the medical literature and is predicated on the princip= les of evidence-based medicine (EBM)=2E

This webinar is being offered by GRC Educators to provide de= tailed information to help manufacturers of newly-developed medical devices= understand why coverage of their product by insurers is primarily determin= ed by top-quality research data published in well-designed clinical trials = published in the medical literature and is predicated on the principles of = evidence-based medicine (EBM)=2E

The targeted audience is medical device manufacturers who ar= e seeking guidance on how to obtain coverage for their new and innovative m= edical devices=2E

Learning Objectives:
  • The Basics of Reimbursement for Medical Devices
  • Determinants Insurers Use to Grant Coverage for New M= edical Devices
  • What is Evidence-Based Medicine and Why its Role is v= ital in obtaining coverage
  • The Hierarchy of Clinical Trial Designs
  • This webinar is intended to provide insight on how ma= nufacturers must conduct the appropriate clinical trials built on the tenet= s of evidence-based medicine to acquire sufficient scientific proof of clin= ical effectiveness necessary to guarantee coverage=2E

 

<=21--=5Bif mso=5D>
<=21=5Bendif=5D-->
<=21--=5Bif mso=5D> <=21=5Bendif=5D--><=21--=5Bif mso=5D> <=21=5Bendif=5D--><=21--=5Bif mso=5D>
<=21=5Bendif=5D-->
  REGISTER NOW 
<=21--=5Bif mso=5D>
<=21=5Bendif=5D-->
Event Marketing =7C GRC Educators =7C 740-870-0321 =7C support=40grcedu= cators=2Ecom =7C www=2Egrceducators=2Ecom =7C 806 Clark Street, P=2EO Box 1= 71, Philo, OH-43771 USA
 
<=21--=5Bif mso=5D> <=21=5Bendif=5D--><=21--=5Bif mso=5D> <=21=5Bendif=5D--><=21--=5Bif mso=5D>
<=21=5Bendif=5D-->
© 2018 GRC Educators
<=21--=5Bif mso=5D>
<=21=5Bendif=5D-->
<=21--=5Bif gte mso 9=5D>
<=21=5Bendif=5D-->